Status:
WITHDRAWN
Atrial Fibrillation Rate Control Therapy Guided By Continuous Ambulatory Monitoring
Lead Sponsor:
Beth Israel Deaconess Medical Center
Collaborating Sponsors:
Cardionet
Conditions:
Atrial Fibrillation
Eligibility:
All Genders
Phase:
NA
Brief Summary
The purpose of this study is to demonstrate that the use of a continuous ambulatory monitoring device will reduce both the time to effective rate control and the health care expenditures associated wi...
Detailed Description
This is an open, randomized controlled trial to compare a standard rate-control strategy with one using the Cardionet device to guide therapy for the management of atrial fibrillation. Patients presen...
Eligibility Criteria
Inclusion
- Atrial fibrillation with resting ventricular rate \> 100 with rate control strategy indicated
- Atrial fibrillation is likely to be recurrent or persistent in the clinical judgment of the physician
- Patient able to be managed out of the hospital
- Ability to sign informed consent
- Ability to wear electrodes for the Cardionet device
- Patient willing to have home patient educator install Cardionet monitor in their home
Exclusion
- Inability to follow up with prescribed schedule of monitoring
- Concomitant use of antiarrhythmic drug
- Indication for hospitalization
Key Trial Info
Start Date :
April 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2006
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00115843
Start Date
April 1 2005
End Date
September 1 2006
Last Update
April 5 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States, 02215